NO993750L - Lipidkomplekser og liposomer fra svært uopplöselige platinakomplekser - Google Patents

Lipidkomplekser og liposomer fra svært uopplöselige platinakomplekser

Info

Publication number
NO993750L
NO993750L NO993750A NO993750A NO993750L NO 993750 L NO993750 L NO 993750L NO 993750 A NO993750 A NO 993750A NO 993750 A NO993750 A NO 993750A NO 993750 L NO993750 L NO 993750L
Authority
NO
Norway
Prior art keywords
complexes
liposomes
highly insoluble
lipid
insoluble platinum
Prior art date
Application number
NO993750A
Other languages
English (en)
Norwegian (no)
Other versions
NO993750D0 (no
Inventor
Mathew Cherian
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of NO993750D0 publication Critical patent/NO993750D0/no
Publication of NO993750L publication Critical patent/NO993750L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6905—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion
    • A61K47/6911—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion the form being a liposome
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO993750A 1997-02-05 1999-08-03 Lipidkomplekser og liposomer fra svært uopplöselige platinakomplekser NO993750L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3737797P 1997-02-05 1997-02-05
PCT/US1998/000035 WO1998033481A1 (en) 1997-02-05 1998-01-28 Lipid complexes and liposomes of highly insoluble platinum complexes

Publications (2)

Publication Number Publication Date
NO993750D0 NO993750D0 (no) 1999-08-03
NO993750L true NO993750L (no) 1999-08-03

Family

ID=21894020

Family Applications (1)

Application Number Title Priority Date Filing Date
NO993750A NO993750L (no) 1997-02-05 1999-08-03 Lipidkomplekser og liposomer fra svært uopplöselige platinakomplekser

Country Status (22)

Country Link
US (1) US6287593B2 (pl)
EP (1) EP0975329B1 (pl)
JP (1) JP2002513396A (pl)
KR (1) KR100578705B1 (pl)
CN (2) CN1191067C (pl)
AT (1) ATE284204T1 (pl)
AU (1) AU749220B2 (pl)
BR (1) BR9815445A (pl)
CA (1) CA2279279C (pl)
DE (1) DE69828038T2 (pl)
DK (1) DK0975329T3 (pl)
EA (1) EA002630B1 (pl)
ES (1) ES2234094T3 (pl)
HK (1) HK1054201B (pl)
HU (1) HUP0001266A3 (pl)
IL (1) IL131008A (pl)
NO (1) NO993750L (pl)
NZ (1) NZ337502A (pl)
PL (1) PL192633B1 (pl)
PT (1) PT975329E (pl)
UA (1) UA71540C2 (pl)
WO (1) WO1998033481A1 (pl)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999051246A1 (en) 1998-04-03 1999-10-14 Ajinomoto Co., Inc. Antitumor agents
US6476068B1 (en) 2001-12-06 2002-11-05 Pharmacia Italia, S.P.A. Platinum derivative pharmaceutical formulations
US9186322B2 (en) * 2002-08-02 2015-11-17 Insmed Incorporated Platinum aggregates and process for producing the same
JP2006525368A (ja) * 2003-05-02 2006-11-09 アロネックス，ファーマシューティカルズ，インコーポレーテッド 脂質白金錯体およびその使用方法
WO2004105732A1 (en) * 2003-05-20 2004-12-09 Aronex Pharmaceuticals, Inc. Combination chemotherapy comprising gemcitabine and a liposomal platinum complex
CA2526289A1 (en) * 2003-05-20 2004-12-02 Aronex Pharmaceuticals, Inc. Combination chemotherapy comprising 5-fluorouracil or a derivative thereof and a liposomal platinum complex
EP1631278A4 (en) * 2003-05-20 2006-09-20 Aronex Pharmaceuticals Inc COMBINATION SCHEMOTHERAPY WITH CAPECITABIN AND A LIPOSOMAL PLATINUM COMPLEX
JP2007504177A (ja) * 2003-09-02 2007-03-01 プリヴァ−ラケマ，エー．エス． 医薬組成物、その製造方法及び治療上の使用
EP1734937A1 (en) * 2004-03-26 2006-12-27 Cell Therapeutics Europe S.R.L. Nanoparticle formulations of platinum compounds
WO2006084248A2 (en) * 2005-02-04 2006-08-10 Antigenics, Inc. Compositions comprising a platinum complex, lipid, and surfactant
US9107824B2 (en) 2005-11-08 2015-08-18 Insmed Incorporated Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
CA2631243A1 (en) * 2005-12-08 2007-06-14 Wyeth Liposomal compositions
CZ300424B6 (cs) * 2006-06-20 2009-05-13 Pliva - Lachema A. S. Farmaceutická kompozice pro perorální podání
IN2012DN02576A (pl) * 2009-09-21 2015-08-28 Jw Pharmaceutical Corportion
WO2012006101A2 (en) 2010-06-28 2012-01-12 The General Hospital Corporation Blood substitutes and uses thereof
CN102276674A (zh) * 2011-06-24 2011-12-14 天津大学 用于肿瘤靶向治疗的含半乳糖铂配合物及其制备方法
CN102286049A (zh) * 2011-06-24 2011-12-21 天津谷堆生物医药科技有限公司 用于肿瘤治疗的水溶性铂配合物及其制备方法
CN102286050A (zh) * 2011-06-24 2011-12-21 天津大学 用于肿瘤靶向治疗的含葡萄糖铂配合物及其制备方法
CN102716145A (zh) * 2012-06-20 2012-10-10 天津谷堆生物医药科技有限公司 含糖铂配合物在制备防治肿瘤药物的用途
EP2874605A1 (en) 2012-07-18 2015-05-27 Onyx Therapeutics, Inc. Liposomal compositions of epoxyketone-based proteasome inhibitors
DK2892524T3 (da) 2012-09-04 2021-01-25 Eleison Pharmaceuticals LLC Forebyggelse af pulmonalt kræfttilbagefald med lipid-komplekseret cisplatin
US10039716B2 (en) 2013-03-13 2018-08-07 Mallinckrodt Llc Liposomal cisplatin compositions for cancer therapy
CN104546722B (zh) * 2015-02-10 2017-05-24 中国医学科学院医药生物技术研究所 米铂脂质体和制法
CN109678910B (zh) * 2016-01-25 2021-09-07 沈阳药科大学 一种化合物及其应用以及一种铂类配合物及其脂质体
JP2020500020A (ja) 2016-11-14 2020-01-09 ノバルティス アーゲー 融合誘導性タンパク質ｍｉｎｉｏｎに関連する組成物、方法、および治療上の使用
CN114652680A (zh) * 2020-12-24 2022-06-24 沈阳药科大学 制备脂质体的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0113508A1 (en) * 1982-11-04 1984-07-18 Inco Research & Development Center, Inc. Hydrophobic platinum compounds and their preparation
US5384127A (en) * 1985-10-18 1995-01-24 Board Of Regents, The University Of Texas System Stable liposomal formulations of lipophilic platinum compounds
US4927571A (en) * 1987-05-18 1990-05-22 Liposome Technology, Inc. Preparation of injectable doxorubicin/liposome suspension
CA1339034C (en) * 1988-08-22 1997-04-01 Paul A. Tremblay Platinum complexes of single isomer neoalkyl acids
US5393909A (en) * 1988-11-22 1995-02-28 Board Of Regents, The University Of Texas System Diamine platinum complexes as antitumor agents
JPH03200795A (ja) * 1989-12-28 1991-09-02 Nippon Kayaku Co Ltd 脂質親和性白金錯体及びそれを含有する製剤
US5843475A (en) * 1996-12-06 1998-12-01 Board Of Regents, The University Of Texas System Delivery and activation through liposome incorporation of diaminocyclohexane platinum (II) complexes

Also Published As

Publication number Publication date
AU749220B2 (en) 2002-06-20
AU6015498A (en) 1998-08-25
CN1191067C (zh) 2005-03-02
HK1029059A1 (zh) 2001-03-23
ATE284204T1 (de) 2004-12-15
KR100578705B1 (ko) 2006-05-12
CN1096263C (zh) 2002-12-18
NO993750D0 (no) 1999-08-03
CA2279279C (en) 2008-10-14
CN1264295A (zh) 2000-08-23
CN1422619A (zh) 2003-06-11
ES2234094T3 (es) 2005-06-16
HUP0001266A2 (hu) 2000-11-28
KR20000070771A (ko) 2000-11-25
NZ337502A (en) 2001-02-23
EA199900715A1 (ru) 2000-04-24
JP2002513396A (ja) 2002-05-08
DE69828038D1 (de) 2005-01-13
DK0975329T3 (da) 2005-03-14
EA002630B1 (ru) 2002-08-29
CA2279279A1 (en) 1998-08-06
DE69828038T2 (de) 2005-11-03
EP0975329B1 (en) 2004-12-08
IL131008A (en) 2003-06-24
EP0975329A1 (en) 2000-02-02
WO1998033481A1 (en) 1998-08-06
IL131008A0 (en) 2001-01-28
US20010010822A1 (en) 2001-08-02
HUP0001266A3 (en) 2001-02-28
PL334940A1 (en) 2000-03-27
US6287593B2 (en) 2001-09-11
HK1054201A1 (en) 2003-11-21
HK1054201B (zh) 2005-09-09
BR9815445A (pt) 2001-09-25
PL192633B1 (pl) 2006-11-30
UA71540C2 (uk) 2004-12-15
PT975329E (pt) 2005-03-31

Similar Documents

Publication Publication Date Title
NO993750D0 (no) Lipidkomplekser og liposomer fra svaert uopplöselige platinakomplekser
DE69616523D1 (de) Verfahren zur baladung von lipidvesikeln
ATE223232T1 (de) Tocopherolzusammensetzungen zur abgabe von biologisch aktiven substanzen
DK0758248T3 (da) Formuleringer til faktor IX
HUP0004396A2 (hu) A lipoprotein-oxidáció gátlására szolgáló, hatóanyagként hidroxilezett koleszterincsökkentő szert tartalmazó gyógyszerkészítmények
AU3559895A (en) Polyethylene glycol modified ceramide lipids and liposome uses thereof
IS5409A (is) Útskipt karboxamídóþíasól, framleiðsla þeirra og lyfjablöndur sem innihalda þau
ATE554750T1 (de) Hydrophobe pharmazeutische wirkstoffe enthaltende zubereitungen
HUP9801370A3 (en) Stable protein:phospholipid compositions and methods for production thereof
ATE195721T1 (de) Lipopolyamine als transfectionsmittel und ihre pharmazeutischen anwendungen
EE200000791A (et) Uudsed atsüülpseudopeptiidid, nende valmistamise meetod ja neid sisaldavad farmatseutilised kompositsioonid
ATE260644T1 (de) Peptid/lipid-komplexbildung durch co- lyophilisation
NO304982B1 (no) Fosfolipid, fosfatidyletanolamin, farmas°ytisk, nµrings eller kosmetisk blanding omfattende nevnte fosfolipid eller fosfatidyletanolamin
MY111841A (en) Injectable liposomal pharmaceutical preparations
TR200001977T2 (tr) Lipofilik glukokortikosteroit içeren miseller ihtiva eden bileşimler
FI960032L (fi) Farmaseuttisia koostumuksia vaikeasti liukenevia aktiiviaineita varten
TR200200785T2 (tr) 8-Fenil-6,9-dihidro-[1,2,4] triazolo [3,4-i] purin-5-on türevleri
TR199801861T2 (xx) Farmas�tik olarak yararl� bile�imler.
ATE322255T1 (de) Polyamid-oligomere
EE9800069A (et) Bensotiasolooni derivaadid, protsessid ja kasutatud vaheühendid nende saamiseks ning neid sisaldavad ravimkoostised
CA2326348A1 (en) Liposomal bupivacaine compositions and methods of preparation
ATE226065T1 (de) Feste instant-release-darreichungsformen und verfahren zu ihrer herstellung
ES2128710T3 (es) Liposomas que contienen proteinas encapsuladas, procedimiento para su produccion asi como las preparaciones farmaceuticas y cosmeticas que contienen estos liposomas.
ATE227295T1 (de) Phosphin- und phosphonsäurederivate als arzneimittel
PT989994E (pt) Derivados de estreptograminas, a sua preparacao e as composicoes que os contem